DF-006 is a first-in-class, orally administered ALPK1 agonist immunomodulator that potently stimulates local, innate immunity in the liver 1. DF-006 has successfully completed single and multiple ...

The innate immune system serves as the body's first line of defence, rapidly detecting and responding to external pathogens and internal damage. Recent advances in the field have highlighted the ...

Drug Farm, a private biotechnology company utilizing genetics and artificial intelligence technologies to discover and develop innovative, immune-modulating therapies, today announced that the chronic ...

SHANGHAI & GUILFORD, Conn.--(BUSINESS WIRE)--Drug Farm, a China- and US-based biotechnology company utilizing genetics and AI technologies to discover and develop innovative, immune-modulating ...

The innate immune system in mammals defends against infection from viruses and other microbial infections. Unfortunately, the human immune response to the hepatitis B virus (HBV) is not yet fully ...

New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in the journal Diagnostics ...

Despite a preventative vaccine, cases of chronic hepatitis B (CHB) continue to rise, with an estimated 254 million persons infected worldwide and 1.1 million deaths per year from HBV-related liver ...

Please provide your email address to receive an email when new articles are posted on . Adults with HBV immunity have 15% lower risk for diabetes than those who do not have immunity. The risk for ...

Hepatitis B virus (HBV) reactivation may occur if someone has chronic HBV, prior exposure to HBV and is undergoing treatment, or a health condition that suppresses their immune system. The hepatitis B ...

Humans are protected by two branches of the immune system. Innate immunity provides built-in defense against widespread characteristics of bacteria and viruses, while adaptive immunity memorizes ...

Background: The duration of protection after hepatitis B vaccination of infants is unknown. Methods: We determined antibody to hepatitis B surface antigen (anti-HBs) at 4-13 years of age in 363 low ...